ArticlePharmaceutics2021

Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis.

Ruben Faelens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.